What do systematic reviews say?

Individual level interventions vs control

The review found no eligible studies for this question.

• Individual‐level interventions to reduce personal exposure to outdoor air pollution and their effects on people with… 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Oral + inhaled dual therapy vs oral monotherapy

• Dual antibiotics for bronchiectasis 2018 · Cochrane Headline outcomes only
  no estimate extracted
  0 studies · 0 participants
  GRADE not reported

Individual TF‐CBT vs EMDR

The review found no eligible studies for this question.

• Psychological interventions for post‐traumatic stress disorder (PTSD) in people with severe mental illness 2017 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings ‐ dual therapy: lumacaftor plus ivacaftor vs placebo

The review found no eligible studies for this question.

• Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants… 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings ‐ dual therapy: tezacaftor plus ivacaftor vs placebo or ivacaftor alone

The review found no eligible studies for this question.

• Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants… 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings ‐ dual therapy: lumacaftor plus ivacaftor (twice daily) vs placebo

The review found no eligible studies for this question.

• Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants… 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Individual TF‐CBT vs Brief PTSD psychoeducation

• Psychological interventions for post‐traumatic stress disorder (PTSD) in people with severe mental illness 2017 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 49 participants
  Low

Individual TF‐CBT vs inactive control (usual care care, attention control, waitlist)

• Psychological interventions for post‐traumatic stress disorder (PTSD) in people with severe mental illness 2017 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 39 participants
  Low

Summary of findings ‐ dual therapy: lumacaftor plus ivacaftor vs placebo

The review found no eligible studies for this question.

• Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants… 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings ‐ dual therapy: tezacaftor plus ivacaftor vs placebo or ivacaftor alone

• Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants… 2023 · Cochrane Headline outcomes only
  no estimate extracted
  5 studies · 946 participants
  Low

Summary of findings ‐ dual therapy: lumacaftor plus ivacaftor (once daily) vs placebo

• Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants… 2023 · Cochrane Headline outcomes only
  no estimate extracted
  3 studies · 1139 participants
  Moderate

Summary of findings ‐ dual therapy: lumacaftor plus ivacaftor (twice daily) vs placebo

• Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants… 2023 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 204 participants
  Low

Summary of findings table ‐ Platelet transfusion vs no platelet transfusion

The review found no eligible studies for this question.

• Use of platelet transfusions prior to lumbar punctures or epidural anaesthesia for the prevention of complications in… 2018 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings ‐ dual therapy: lumacaftor plus ivacaftor (once daily) vs placebo

• Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants… 2023 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 1061 participants
  Moderate

Reminiscence therapy vs no treatment

• Reminiscence therapy for dementia 2018 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 23 participants
  Low

Summary of findings: Picture Exchange Communication System (PECS) vs treatment

The review found no eligible studies for this question.

• Communication interventions for autism spectrum disorder in minimally verbal children 2018 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings: focused playtime intervention vs treatment

The review found no eligible studies for this question.

• Communication interventions for autism spectrum disorder in minimally verbal children 2018 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Group cognitive behavioural therapy for psychosis vs usual care

The review found no eligible studies for this question.

• Cognitive behavioural therapy (group) for schizophrenia 2022 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

VALPROATE + ANTIPSYCHOTICS vs placebo/no adjunctive treatment + antipsychotics

• Valproate for schizophrenia 2016 · Cochrane Headline outcomes only
  no estimate extracted
  0 participants
  GRADE not reported

Humour‐based interventions vs usual care

The review found no eligible studies for this question.

• Humour‐based interventions for people with schizophrenia 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found